跳至主要内容
临床试验/CTRI/2020/09/027750
CTRI/2020/09/027750尚未招募1 期

EFFICACY OF BRAHMI VATI WITH SARASWATARISHTA OVER ESCITALOPRAM IN GENERALIZED ANXIETY DISORDER -A RANDOMIZED CONTROLLED CLINICAL TRIA

DR VARSHA BALKRISHNA GONUGADE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Subjects fulfilling the diagnostic criteria of GAD (DSM V)

排除标准

  • 1 Laxana of Unmada (co-morbid psychiatric disorders)
  • 2 Psychotropic drugs four weeks prior to study.
  • 3 Patients with substance abuse like alcohol etc.
  • 4 Patients with significant depression (BDI >17).
  • 5 The patients with any other medical (Hypertension, Diabetes Mellitus)
  • 6 Female patients who are pregnant and lactating.

研究者

发起方
DR VARSHA BALKRISHNA GONUGADE

相似试验